Consumer Health

AirTree Ventures (Web3)

Check: Neither Airtree nor Elicia publishes her personal check range or decision authority. Airtree describes itself as seed-first and able to support companies through their journey; a historic Fund III article mentioned a $200k seed entry point, but that is firm- and vintage-specific rather than a current personal range.

Elicia backs highly ambitious, resilient founders from Australia and New Zealand, often beginning at pre-seed or seed and supporting them across later rounds. Her disclosed portfolio spans AI-enabled enterprise software, workforce intelligence, healthcare, agricultural and climate technology, and B2B SaaS. Her writing emphasizes technology's capacity for positive impact, founder ambition, durable relationships, product love, domain depth, and accepting concentrated venture risk in pursuit of outlier outcomes.

BoxGroup

Check: No reliable Arielle-specific check size is public. BoxGroup describes itself as an earliest-stage investor, but founders should confirm current round fit and allocation directly rather than relying on third-party range estimates.

Arielle invests within BoxGroup's broad earliest-stage mandate. Her differentiated documented context is technical and translational: Harvard bioengineering research, founding a postpartum medical-device project, product work in fertility AI and neuromodulation, mechanical engineering at a bioelectronic-medicine startup, and consulting at BCG. This supports a credible ability to evaluate user need, clinical workflow, product design, manufacturing, regulatory planning and commercialization in technical health businesses. It does not establish an exclusive healthcare mandate or a personally published investment thesis.

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Ita Ekpoudom as Supporting Partner. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Stephanie Urbanski as Managing Partner. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Johannes Blaschke as Partner. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Ekaterina Gianelli as Venture Partner. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Paul Varga as Venture Partner. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Philippa Allen as Investment Manager. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Michela Grimaldi as Communications Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Nina Kasmaei-Gatzmaga as Founders Associate. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Julinka Waesche as Visiting Analyst. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Matteo Vannucchi as Visiting Analyst. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Matheus Verweijen as Junior Finance Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Tim Schneider as Supporting Partner. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Haymo Meran as Supporting Partner. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

BoxGroup

Check: BoxGroup publicly invests up to $1M. Third-party profiles estimate Disha's range at $500K–$1M, but no primary source confirms a personal range, so the firm ceiling is the safer planning assumption.

Disha invests at the earliest stages with a differentiated mix of finance, neuroscience, biotech R&D, and prior growth-investing exposure. Her public investor profile points to AI, enterprise infrastructure and software, digital and consumer health, biotech, and commerce. Within BoxGroup's generalist model, the through-line is an exceptional founder using technical or domain insight to create a category, not a rigid sector checklist.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

David Schonthal is listed in a Operating Partner capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Tom Richards is listed in a Operating Partner capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Cameron Raglin invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Joslin Owens is listed in a Director of Finance capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Sathya Shanthakumar is listed in a Director of Investor Relations capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Lynne Chou O'Keefe invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Bruce Broussard invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Frank Williams invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Carolyn Magill invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Karsten Vagner is listed in a Head of People capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Shannon Knous is listed in a VP of Finance & Operations capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Lauren O'Mahony is listed in a Head of Marketing capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Katharine Morris is listed in a Administrative Assistant & Office Manager capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.

GreyMatter

Check: GreyMatter does not publish a standard current check-size range on its official site.

Danish Munir invests or supports investments through GreyMatter's published strategy: Back early founders transforming mental health through better access, outcomes, infrastructure, science and experiences.

GreyMatter

Check: GreyMatter does not publish a standard current check-size range on its official site.

Anna Wang invests or supports investments through GreyMatter's published strategy: Back early founders transforming mental health through better access, outcomes, infrastructure, science and experiences.

GreyMatter

Check: GreyMatter does not publish a standard current check-size range on its official site.

Andrew Barr invests or supports investments through GreyMatter's published strategy: Back early founders transforming mental health through better access, outcomes, infrastructure, science and experiences.

GreyMatter

Check: GreyMatter does not publish a standard current check-size range on its official site.

Natalie Bartlett invests or supports investments through GreyMatter's published strategy: Back early founders transforming mental health through better access, outcomes, infrastructure, science and experiences.

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Lucanus Polagnoli as Founding Partner. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Glen Tullman invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Lee Shapiro invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Robert Garber invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Alyssa Jaffee invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Chuka Esiobu invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Garrett Howard invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Michael Wert invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Hong Truong invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Anish Aitharaju invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Erin Hardy is listed in a Accounting & Operations Manager capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Chirag Shah invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Tiffany Yu invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Eric Shan invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.

Define Ventures

Silicon Valley, California

Calm/Storm Ventures

Vienna, Austria

7wire Ventures

Chicago, Illinois

GreyMatter

United States